Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,720,758 papers from all fields of science
Search
Sign In
Create Free Account
CS 940
Known as:
CS-940
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Fluoroquinolones
Piperazines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2007
Review
2007
Emerging trends in tuberculosis therapy : A review
Y. Agrawal
,
Hardik G. Bhatt
,
+5 authors
S. Highway
2007
Corpus ID: 91216459
on TB estimates that between 2000 and 2020, nearly one billion people will get sick and 35 million will die from TB. In India…
Expand
Review
2005
Review
2005
Fluoroquinolones and Tuberculosis: a Review
A. Bryskier
,
J. Lowther
2005
Corpus ID: 53832189
Some fluoroquinolones have been demonstrated to be effective companions in standard regimens of tuberculosis (TB) therapy, but…
Expand
Review
1999
Review
1999
[View of development of fluoroquinolones].
K. Namba
Kekkaku : [Tuberculosis]
1999
Corpus ID: 43650952
The global resurgence of tuberculosis and the emergence of multidrug-resistant tuberculosis have emphasized an urgent need for…
Expand
Review
1998
Review
1998
[Chemotherapeutic agents under study].
S. Kawahara
Nihon rinsho. Japanese journal of clinical…
1998
Corpus ID: 26549278
The development of new drugs with strong antituberculous activity and fewer side effects which are not cross-resistant to…
Expand
1996
1996
[Determination of antimycobacterial activities of fluoroquinolones against clinical isolates of Mycobacterium tuberculosis: comparative determination with egg-based Ogawa and agar-based Middlebrook…
N. Yamane
,
B. Chilima
,
M. Tosaka
,
Y. Okazawa
,
K. Tanno
Kekkaku : [Tuberculosis]
1996
Corpus ID: 45226860
The minimum inhibitory concentrations (MICs) to the fluoroquinolones, ofloxacin (OFLX), ciprofloxacin (CPFX), sparfloxacin (SPFX…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE